Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nilsson

Showing results (211-220 of 1,735) with videos related to

Pageof 174
Sort By:
Scandinavian Journal of Haematology|January 1, 1973
Pattern of the activator inhibitor in carcinoma and renal diseasesU Hedner, I M Nilsson
Lakartidningen|March 29, 2008
[Certain eponyms ethically doubtful. The historical background is important for stimulation of critical thinking]Peter M Nilsson, Nils Hansson
Lakartidningen|May 16, 2008
[What is really an optimal treatment in type 2 diabetes? New studies call for reflection]Peter M Nilsson, Björn Eliasson
Svensk Medicinhistorisk Tidskrift|December 13, 2006
[Public health in eastern Skania 1860-1899--a study based on district medical officer's reports]Malin Appelquist, Peter M Nilsson
Clinics in Haematology|June 1, 1985
Von Willebrand diseaseL Holmberg, I M Nilsson
Lancet (London, England)|February 23, 1985
High-dose intravenous gammaglobulin: a cautionary noteR Ljung, I M Nilsson
Lakartidningen|October 26, 2007
[Short telomere length a marker of premature vascular aging]Peter M Nilsson, Frej Fyhrquist
Diabetologia|August 15, 2024
Reduced type 2 diabetes incidence reflecting end of post-World War II calorie restrictions in GermanyPeter M Nilsson, Allan Vaag
British Medical Journal|June 5, 1971
Blood clotting and contraceptionI M Nilsson, B Astedt
Lancet (London, England)|September 14, 1974
Letter: Haemophilia carriersI M Nilsson, L Holmberg
Pageof 174

Showing results (211-220 of 1,735) with videos related to

Sort By:
Pageof 174
Scandinavian Journal of Haematology|January 1, 1973
Pattern of the activator inhibitor in carcinoma and renal diseasesU Hedner, I M Nilsson
Lakartidningen|March 29, 2008
[Certain eponyms ethically doubtful. The historical background is important for stimulation of critical thinking]Peter M Nilsson, Nils Hansson
Lakartidningen|May 16, 2008
[What is really an optimal treatment in type 2 diabetes? New studies call for reflection]Peter M Nilsson, Björn Eliasson
Svensk Medicinhistorisk Tidskrift|December 13, 2006
[Public health in eastern Skania 1860-1899--a study based on district medical officer's reports]Malin Appelquist, Peter M Nilsson
Clinics in Haematology|June 1, 1985
Von Willebrand diseaseL Holmberg, I M Nilsson
Lancet (London, England)|February 23, 1985
High-dose intravenous gammaglobulin: a cautionary noteR Ljung, I M Nilsson
Lakartidningen|October 26, 2007
[Short telomere length a marker of premature vascular aging]Peter M Nilsson, Frej Fyhrquist
Diabetologia|August 15, 2024
Reduced type 2 diabetes incidence reflecting end of post-World War II calorie restrictions in GermanyPeter M Nilsson, Allan Vaag
British Medical Journal|June 5, 1971
Blood clotting and contraceptionI M Nilsson, B Astedt
Lancet (London, England)|September 14, 1974
Letter: Haemophilia carriersI M Nilsson, L Holmberg
Pageof 174